☰

Omar A. Ibrahimi, Ph.D. - Publications

Affiliations: 
2004 New York University, New York, NY, United States 
Area:
Biochemistry, Pathology
Tree Info Similar researchers PubMed Report error

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Beenken A, Eliseenkova AV, Ibrahimi OA, Olsen SK, Mohammadi M. Plasticity in interactions of fibroblast growth factor 1 (FGF1) N terminus with FGF receptors underlies promiscuity of FGF1. The Journal of Biological Chemistry. 287: 3067-78. PMID 22057274 DOI: 10.1074/Jbc.M111.275891  0.784
2009 Gartside MG, Chen H, Ibrahimi OA, Byron SA, Curtis AV, Wellens CL, Bengston A, Yudt LM, Eliseenkova AV, Ma J, Curtin JA, Hyder P, Harper UL, Riedesel E, Mann GJ, et al. Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma. Molecular Cancer Research : McR. 7: 41-54. PMID 19147536 DOI: 10.1158/1541-7786.Mcr-08-0021  0.632
2007 Goetz R, Beenken A, Ibrahimi OA, Kalinina J, Olsen SK, Eliseenkova AV, Xu C, Neubert TA, Zhang F, Linhardt RJ, Yu X, White KE, Inagaki T, Kliewer SA, Yamamoto M, et al. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Molecular and Cellular Biology. 27: 3417-28. PMID 17339340 DOI: 10.1128/Mcb.02249-06  0.705
2007 Pitteloud N, Quinton R, Pearce S, Raivio T, Acierno J, Dwyer A, Plummer L, Hughes V, Seminara S, Cheng YZ, Li WP, Maccoll G, Eliseenkova AV, Olsen SK, Ibrahimi OA, et al. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism Journal of Clinical Investigation. 117: 457-463. PMID 17235395 DOI: 10.1172/Jci29884  0.693
2006 Pitteloud N, Acierno JS, Meysing A, Eliseenkova AV, Ma J, Ibrahimi OA, Metzger DL, Hayes FJ, Dwyer AA, Hughes VA, Yialamas M, Hall JE, Grant E, Mohammadi M, Crowley WF. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proceedings of the National Academy of Sciences of the United States of America. 103: 6281-6. PMID 16606836 DOI: 10.1073/Pnas.0600962103  0.577
2006 Zhang X, Ibrahimi OA, Olsen SK, Umemori H, Mohammadi M, Ornitz DM. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. The Journal of Biological Chemistry. 281: 15694-700. PMID 16597617 DOI: 10.1074/Jbc.M601252200  0.794
2006 Olsen SK, Li JY, Bromleigh C, Eliseenkova AV, Ibrahimi OA, Lao Z, Zhang F, Linhardt RJ, Joyner AL, Mohammadi M. Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain. Genes & Development. 20: 185-98. PMID 16384934 DOI: 10.1101/Gad.1365406  0.806
2006 Pollock P, Gartside M, Ibrahimi O, Curtis A, Yudt L, Curtin J, Mann G, Bastian B, Meltzer P, Mohammadi M. Functional characterization of FGFR2 mutations in melanoma reveals multiple mechanisms of inactivation Melanoma Research. 16: S97. DOI: 10.1097/00008390-200609001-00178  0.478
2005 Yu X, Ibrahimi OA, Goetz R, Zhang F, Davis SI, Garringer HJ, Linhardt RJ, Ornitz DM, Mohammadi M, White KE. Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23. Endocrinology. 146: 4647-56. PMID 16081635 DOI: 10.1210/En.2005-0670  0.723
2005 Mohammadi M, Olsen SK, Ibrahimi OA. Structural basis for fibroblast growth factor receptor activation. Cytokine & Growth Factor Reviews. 16: 107-37. PMID 15863029 DOI: 10.1016/J.Cytogfr.2005.01.008  0.811
2005 Ibrahimi OA, Yeh BK, Eliseenkova AV, Zhang F, Olsen SK, Igarashi M, Aaronson SA, Linhardt RJ, Mohammadi M. Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization. Molecular and Cellular Biology. 25: 671-84. PMID 15632068 DOI: 10.1128/Mcb.25.2.671-684.2005  0.795
2005 Ibrahimi OA, Chiu ES, McCarthy JG, Mohammadi M. Understanding the molecular basis of Apert syndrome. Plastic and Reconstructive Surgery. 115: 264-70. PMID 15622262 DOI: 10.1097/01.Prs.0000146703.08958.95  0.523
2004 Ibrahimi OA, Zhang F, Eliseenkova AV, Itoh N, Linhardt RJ, Mohammadi M. Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities. Human Molecular Genetics. 13: 2313-24. PMID 15282208 DOI: 10.1093/Hmg/Ddh235  0.652
2004 Ibrahimi OA, Zhang F, Hrstka SC, Mohammadi M, Linhardt RJ. Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly. Biochemistry. 43: 4724-30. PMID 15096041 DOI: 10.1021/Bi0352320  0.727
2004 Olsen SK, Ibrahimi OA, Raucci A, Zhang F, Eliseenkova AV, Yayon A, Basilico C, Linhardt RJ, Schlessinger J, Mohammadi M. Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity. Proceedings of the National Academy of Sciences of the United States of America. 101: 935-40. PMID 14732692 DOI: 10.1073/Pnas.0307287101  0.777
2004 Ibrahimi OA, Zhang F, Eliseenkova AV, Linhardt RJ, Mohammadi M. Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity. Human Molecular Genetics. 13: 69-78. PMID 14613973 DOI: 10.1093/Hmg/Ddh011  0.722
2001 Ibrahimi OA, Eliseenkova AV, Plotnikov AN, Yu K, Ornitz DM, Mohammadi M. Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proceedings of the National Academy of Sciences of the United States of America. 98: 7182-7. PMID 11390973 DOI: 10.1073/Pnas.121183798  0.754
2001 Plotnikov AN, Eliseenkova AV, Ibrahimi OA, Shriver Z, Sasisekharan R, Lemmon MA, Mohammadi M. Crystal structure of fibroblast growth factor 9 reveals regions implicated in dimerization and autoinhibition. The Journal of Biological Chemistry. 276: 4322-9. PMID 11060292 DOI: 10.1074/Jbc.M006502200  0.724
2000 Schlessinger J, Plotnikov AN, Ibrahimi OA, Eliseenkova AV, Yeh BK, Yayon A, Linhardt RJ, Mohammadi M. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Molecular Cell. 6: 743-50. PMID 11030354 DOI: 10.1016/S1097-2765(00)00073-3  0.715
Show low-probability matches.